GastroCare™

Description

Symptoms of upper gastrointestinal discomfort are among the most common patient complaints. Supporting the healing process of oral, esophageal, gastric, and abdominal tissues requires more than just treating symptoms. Deglycyrrhizinated licorice (DGL) is rich in flavonoids and chalcones, among other constituents, that favorably yet safely influence mucosal health by a number of mechanisms. Slippery elm bark contains a mucilage component with soothing properties ideally suited for protecting the tissues of the upper gastrointestinal tract. Zinc has several functions essential for healing disturbed tissues, including those of the upper digestive tract. These therapies are combined in a pleasant-tasting chewable tablet, since capsules do not allow the development of the soothing coating action required for maximal effectiveness.

• Deglycyrrhizinated licorice (DGL) contains flavonoids and chalcones exhibiting multiple protective effects on gastric mucosal tissues (Comp Biochem Physiol 1996;113C:17-21; Planta Med 1992;58:389-93; Eur J Pharmacol 1981;72:219-25), but it is free of potentially hazardous glycyrrhizin that occurs naturally in licorice (Food Chem Toxicol 1993;31:303-12).
• DGL has repeatedly demonstrated effectiveness in supporting normal growth and repair processes in the mouth and upper digestive tract according to controlled human trials (Gut 1985; 26:599-602; Gut 1982;23:545-51; Phytother Res 2009;23:246-50; J Contemp Dent Pract 2008;9:88-98).
• The topical benefits of DGL (J Assoc Phys India 1989;37:647) and the clinical failure of forms that did not interact with saliva (Gut 1978;19:779-82; Practitioner 1975;215:787-92) emphasize the necessity of a chewable DGL tablet.
• Slippery elm bark contains a mucilage component with soothing properties ideally suited for protecting the tissues of the upper gastrointestinal tract. (J Pain Symptom Manage 1997;14:1-2)
• Zinc has several functions essential for healing, and has significantly improved growth and repair processes in the upper digestive tract compared with placebo in double-blind research (Med J Aust 1975;2:793-6).

Suggested use for adults: Two chewable tablets 30 minutes before meals, three times daily, or as directed.